Selective inhibition of hepatitis B virus internalization by oxysterol derivatives
Mizuki Oshima(Tokyo University of Science), Koichi Watashi(Tokyo University of Science), Kouji Kuramochi(Kyoto Prefectural University), Masamichi Muramatsu(National Institute of Infectious Diseases), Frank Stappenbeck(Max Biopharma (United States)), Farhad Parhami(University of California, Los Angeles), Camille Sureau(Génomes, biologie cellulaire et thérapeutiques), Masashi Iwamoto(Rockefeller University), Kento Fukano(Meiji Pharmaceutical University), Feng Wang(Max Biopharma (United States)), Atsuto Kusunoki(National Institute of Infectious Diseases), Hirofumi Ohashi(National Institute of Infectious Diseases), Ryosuke Suzuki(National Institute of Infectious Diseases), Ryo Morishita(Matsuyama University), Xin Zheng(National Institute of Infectious Diseases), Hideki Aizaki(National Institute of Infectious Diseases)
Cited by 10
Related Papers
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
The lipid droplet is an important organelle for hepatitis C virus production
|Nature Cell Biology|2007|1.2k
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
|Biochemical and Biophysical Research Communications|2013|330
Oxysterols Are Novel Activators of the Hedgehog Signaling Pathway in Pluripotent Mesenchymal Cells
|Journal of Biological Chemistry|2007|298